Measurement of tumor cytolysis by macrophages

Current Protocols in Immunology

Volumn , Issue SUPPL.92, 2011, Pages

  Escórcio Correia, Mónica ^a   Hagemann, Thorsten ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

7 AAD; Annexin V; CFDA SE; Cytolysis; Macrophages; Tumor

Indexed keywords

CARBOXYFLUORESCEIN DIACETATE SUCCINIMIDYL ESTER; RADIOISOTOPE;

ARTICLE; CELL DEATH; CELL LABELING; COCULTURE; CYTOTOXICITY; EFFECTOR CELL; ISOTOPE LABELING; MACROPHAGE; MACROPHAGE ACTIVATION; NONHUMAN; PRIORITY JOURNAL; TARGET CELL; TUMOR CELL DESTRUCTION; TUMOR CELL LINE;

EID: 79953195213     PISSN: 19343671     EISSN: 1934368X     Source Type: Journal    
DOI: 10.1002/0471142735.im1418s92     Document Type: Article

References (17)

1. Bingle, L., Brown, N.J., and Lewis, C.E. 2002. The role of tumour-associated macrophages in tumour progression: Implications for new anticancer therapies. J. Pathol. 196:254-265.
2. Bracher, M., Gould, H.J., Sutton, B.J., Dombrowicz, D., and Karagiannis, S.N. 2007. Three-colour flow cytometric method to measure antibody-dependent tumour cell killing by cytotoxicity and phagocytosis. J. Immunol. Methods 323:160-171.
3. Buhtoiarov, I.N., Lum, H., Berke, G., Paulnock, D.M., Sondel, P.M., and Rakhmilevich, A.L. 2005. CD40 ligation activates murine macrophages via an IFN-{gamma}-dependent mechanism resulting in tumor cell destruction in vitro. J. Immunol. 174:6013-6022.
4. Buhtoiarov, I.N., Lum, H.D., Berke, G., Sondel, P.M., and Rakhmilevich, A.L. 2006. Synergistic activation of macrophages via CD40 and TLR9 results in T cell independent antitumor effects. J. Immunol. 176:309-318.
5. Chen, G.G., Chu, Y.S., Chak, E.C., Leung, B.C., and Poon, W.S. 2002. Induction of apoptosis in glioma cells by molecules released from activated macrophages. J. Neurooncol. 57:179-186.
6. Hagemann, T., Lawrence, T., McNeish, I., Charles, K.A., Kulbe, H., Thompson, R.G., Robinson, S.C., and Balkwill, F.R. 2008. "Re-educating" tumor-associated macrophages by targeting NF-{kappa}B. J. Exp. Med. 205:1261-1268.
7. Held, T.K., Weihua, X., Yuan, L., Kalvakolanu, D.V., and Cross, A.S. 1999. Gamma interferon augments macrophage activation by lipopolysaccharide by two distinct mechanisms, at the signal transduction level and via an autocrine mechanism involving tumor necrosis factor alpha and interleukin-1. Infect. Immun. 67:206-212.
8. Kawamura, K., Bahar, R., Natsume, W., Sakiyama, S., and Tagawa, M. 2002. Secretion of interleukin-10 from murine colon carcinoma cells suppresses systemic antitumor immunity and impairs protective immunity induced against the tumors. Cancer Gene Ther. 9:109-115.
9. Kloss, S., Bochennek, K., Huenecke, S., Zimmermann, S.Y., Kuci, S., Muller, T., Wels, W.S., Klingebiel, T., Esser, R., and Koehl, U. 2007. A novel five-colour flow cytometric assay to determine NK cell cytotoxicity against neuroblastoma and other adherent tumour cells. J. Immunol. Methods 325:140-147.
10. Koestler, T.P., Johnson, W.J., Rieman, D., Dalton, B.J., Greig, R.G., and Poste, G. 1987. Differential expression of murine macrophage-mediated tumor cytotoxicity induced by interferons. Cancer Res. 47:2804-2808.
11. Leu, R.W., Leu, N.R., Shannon, B.J., and Fast, D.J. 1991. IFN-gamma differentially modulates the susceptibility of L1210 and P815 tumor targets for macrophage-mediated cytotoxicity: Role of macrophage- target interaction coupled to nitric oxide generation, but independent of tumor necrosis factor production. J. Immunol. 147:1816-1822.
12. Lum, H.D., Buhtoiarov, I.N., Schmidt, B.E., Berke, G., Paulnock, D.M., Sondel, P.M., and Rakhmilevich, A.L. 2006. Tumoristatic effects of anti-CD40 mAb-activated macrophages involve nitric oxide and tumour necrosis factor-alpha. Immunology 118:261-270.
13. Mantovani, A., Allavena, P., Sica, A., and Balkwill, F. 2008. Cancer-related inflammation. Nature 454:436-444.
14. Pollard, J.W. 2004. Tumour-educated macrophages promote tumour progression and metastasis. Nat. Rev. Cancer 4:71-78.
15. Roby K.F., Taylor, C.C., Sweetwood, J.P., Cheng, Y., Pace, J.L., Tawfik, O., Persons, D.L., Smith, P.G., and Terranova, P.F. 2000. Development of a syngeneic mouse model for events related to ovarian cancer. Carcinogenesis 21:585-591.
16. Ruco, L.P. and Meltzer, M.S. 1978. Macrophage activation for tumor cytotoxicity: Development of macrophage cytotoxic activity requires completion of a sequence of short-lived intermediary reactions. J. Immunol. 121:2035-2042.
17. Tasaki, K., Yoshida, Y., Maeda, T., Miyauchi, M., Kawamura, K., Takenaga, K., Yamamoto, H., Kouzu, T., Asano, T., Ochiai, T., Sakiyama, S., and Tagawa, M. 2000. Protective immunity is induced in murine colon carcinoma cells by the expression of interleukin-12 or interleukin-18, which activate type 1 helper T cells. Cancer Gene Ther. 7:247-254.